Advocating AMPK’s role in tumor suppression is its activation by the well-characterized tumor suppressor LKB1 [48], the clear anti-cancer potential of AMPK activators (e.g., metformin) [47], and the ability of AMPK to inhibit pro-survival downstream targets, namely mTOR [51]. The gene discussed is STK11; the disease is neoplasm.